生物技术考研，生物技术考研方向及学校
直播时间：9月7日上午8:00-9:00
直播平台：上海技术交易所视频号
特邀讲师：[美]Lita Nelsen
分享内容
在生物科技行业，很多生物企业都是在大学研究中发展出来，专利权归大学所有，技术的使用权力也是通过大学的授权。
本次研讨会将讨论麻省理工学院如何通过其技术许可办公室管理专利申请和许可，以及如何用更多的举措，来鼓励教师和学生的创业精神，从而帮助数百家新的生物技术公司从麻省理工学院和其附属机构怀特黑德研究所，分离出来，创造出更多优秀的企业。
讲师介绍
Lita Nelsen
担任麻省理工学院技术许可办公室主任25年后退休，现在是几家新兴生物技术公司的顾问或董事会成员，也是麻省理工学院Sandbox学生创业项目的导师、早期风险投资公司GoodGrowth Capital的顾问，以及香港大学技术授权讲师。
Content
Discover the driving force behind the dynamic biotech landscape at our seminar. Unveiling the blueprint for success, we delve into the pivotal role of university research in birthing groundbreaking biotech ventures. With a significant proportion of emerging biotech companies tracing their roots back to cutting-edge university discoveries fueled by Federal funding, the seminar illuminates the transformative journey of ideas from academia to the marketplace.
The majority of new biotech companies originate with new discoveries and inventions from university research, most of which was sponsored by Federal funding. Patents from such research are owned by the universities, and rights to them are given to new startups via licensed granted by the university.
This seminar discusses how MIT manages patent filings and licensing through its Technology Licensing Office, and encourages entrepreneurship by faculty and students through its many “Innovation” initiatives. Hundreds of new biotech companies have spun out of MIT and its Whitehead Institute affiliate. Some of the more famous local companies include Alnylam, BluebirdBio, Momenta, and Ginko Bioworks.
Lecturer
Lita Nelsen retired after over 25 years as Director of MIT’s Technology Licensing Office. She is now a consultant or board member to several new biotech companies and a mentor in MIT’s Sandbox student entrepreneurship program and an advisor to GoodGrowth Capital, an early stage venture capital company. She is also a lecturer in technology licensing for Hong Kong University.
关注“全球跨境技术贸易中心”
了解更多讯息
上 技 国 际
-STEX INTERNATIONAL-
生物技术考研(生物技术考研方向及学校)
未经允许不得转载：考研培训网 » 生物技术考研(生物技术考研方向及学校)
